ONCY:NASDAQ
Oncolytics Biotech Inc
$0.63
arrow_downward
-1.59%(-0.010) 1D
$0.65
arrow_upward
+3.00% (+0.019)bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.65
High
$0.65
Low
$0.62
Mkt. cap
80.46M
Avg. vol.
969.28K
Volume
611.81K
52-wk high
$1.42
52-wk low
$0.62
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.65
High
$0.65
Low
$0.62
Mkt. cap
80.46M
Avg. vol.
969.28K
Volume
611.81K
52-wk high
$1.42
52-wk low
$0.62
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
The Motley Fool
·
52 minutes ago
History Says Coca-Cola Stock Holds Up When the S&P 500 Falls
U.S. Global Investors
·
1 day ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
TradingView
·
5 hours ago
Energy sector outperforms S&P 500 in Q3 as oil prices rise
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com